Literature DB >> 4057125

Nonverbal expressiveness and EMG activity in tension headache sufferers and controls.

H C Traue, A Gottwald, P R Henderson, D A Bakal.   

Abstract

This study explored the relationship between musculoskeletal responses and nonverbal expressiveness in response to psychosocial stress. Muscle-contraction headache subjects and normal controls were confronted with a psychological stressor while forehead and neck EMG activity were recorded. Indices of nonverbal expressiveness (head and hand movements, facial tension, facial activity, and facial expressiveness) were obtained concomitantly with the muscle data. The headache subjects showed greater muscle activation than the controls in response to stress, greater evidence of facial tension, and less evidence of facial and bodily expressiveness. Overall, these data provided support for the notion that under some conditions a negative relationship exists between expressiveness and somatic activation.

Entities:  

Mesh:

Year:  1985        PMID: 4057125     DOI: 10.1016/0022-3999(85)90023-6

Source DB:  PubMed          Journal:  J Psychosom Res        ISSN: 0022-3999            Impact factor:   3.006


  5 in total

1.  Tension headache: disregulation at some levels of stress.

Authors:  C A Hovanitz; M R Wander
Journal:  J Behav Med       Date:  1990-12

2.  [Not Available].

Authors:  H C Traue; M Kessler; H C Traue
Journal:  Schmerz       Date:  1988-09       Impact factor: 1.107

Review 3.  [Psychological approaches to pain in Germany. Review and outlook].

Authors:  M Pfingsten; H Flor; P Nilges
Journal:  Schmerz       Date:  2015-10       Impact factor: 1.107

4.  Head movements and postures as pain behavior.

Authors:  Philipp Werner; Ayoub Al-Hamadi; Kerstin Limbrecht-Ecklundt; Steffen Walter; Harald C Traue
Journal:  PLoS One       Date:  2018-02-14       Impact factor: 3.240

5.  Experimentally induced stress validated by EMG activity.

Authors:  Rosan Luijcks; Hermie J Hermens; Lonneke Bodar; Catherine J Vossen; Jim Van Os; Richel Lousberg
Journal:  PLoS One       Date:  2014-04-15       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.